411.49
price up icon2.26%   9.11
after-market アフターアワーズ: 411.49
loading
前日終値:
$402.38
開ける:
$405.45
24時間の取引高:
965.43K
Relative Volume:
1.23
時価総額:
$32.79B
収益:
$3.90B
当期純損益:
$887.87M
株価収益率:
38.57
EPS:
10.67
ネットキャッシュフロー:
$798.08M
1週間 パフォーマンス:
+7.77%
1か月 パフォーマンス:
-2.57%
6か月 パフォーマンス:
-10.55%
1年 パフォーマンス:
-13.96%
1日の値動き範囲:
Value
$402.86
$412.62
1週間の範囲:
Value
$375.06
$412.62
52週間の値動き範囲:
Value
$356.14
$548.88

Idexx Laboratories Inc Stock (IDXX) Company Profile

Name
名前
Idexx Laboratories Inc
Name
セクター
Healthcare (1151)
Name
電話
(207) 556-0300
Name
住所
ONE IDEXX DRIVE, WESTBROOK, ME
Name
職員
11,000
Name
Twitter
@idexx
Name
次回の収益日
2025-02-03
Name
最新のSEC提出書
Name
IDXX's Discussions on Twitter

IDXX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
411.49 32.79B 3.90B 887.87M 798.08M 10.67
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
427.50 169.62B 42.88B 6.34B 7.27B 16.53
Diagnostics & Research icon
DHR
Danaher Corp
186.83 138.06B 23.88B 3.90B 5.30B 5.28
Diagnostics & Research icon
A
Agilent Technologies Inc
102.48 29.99B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
143.91 26.61B 15.41B 1.37B 2.11B 7.50

Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-02 開始されました Leerink Partners Outperform
2024-07-25 開始されました BTIG Research Buy
2024-01-30 ダウングレード Piper Sandler Overweight → Neutral
2023-12-07 開始されました Exane BNP Paribas Outperform
2023-12-04 アップグレード Cleveland Research Neutral → Buy
2023-08-02 ダウングレード Atlantic Equities Overweight → Neutral
2022-07-25 ダウングレード Stifel Buy → Hold
2022-07-21 アップグレード Goldman Neutral → Buy
2022-07-12 開始されました Piper Sandler Overweight
2022-05-05 ダウングレード BofA Securities Buy → Neutral
2022-02-08 開始されました Atlantic Equities Overweight
2021-11-18 開始されました Morgan Stanley Overweight
2021-08-05 再開されました Credit Suisse Outperform
2021-07-12 ダウングレード Guggenheim Buy → Neutral
2021-02-17 開始されました Barclays Overweight
2019-09-09 開始されました Goldman Neutral
2019-05-23 開始されました Guggenheim Buy
2018-11-02 繰り返されました BofA/Merrill Buy
2018-05-07 繰り返されました Stifel Buy
2018-01-16 開始されました Piper Jaffray Overweight
2017-08-23 アップグレード BofA/Merrill Neutral → Buy
2017-07-28 アップグレード CL King Neutral → Buy
2017-02-03 ダウングレード Feltl & Co. Hold → Sell
2016-09-29 再開されました BofA/Merrill Neutral
2016-08-16 繰り返されました Stifel Buy
2016-08-03 アップグレード Northcoast Sell → Neutral
2016-07-20 繰り返されました Canaccord Genuity Buy
2016-04-19 繰り返されました Canaccord Genuity Buy
2016-04-01 開始されました CL King Neutral
2016-03-21 繰り返されました Stifel Buy
2016-02-04 開始されました Credit Suisse Outperform
2015-10-29 繰り返されました Stifel Buy
2015-08-28 ダウングレード Raymond James Outperform → Mkt Perform
2015-08-13 繰り返されました Stifel Buy
2015-07-23 繰り返されました Canaccord Genuity Buy
すべてを表示

Idexx Laboratories Inc (IDXX) 最新ニュース

pulisher
Apr 15, 2025

Morgan Stanley Adjusts IDEXX Laboratories' Price Target to $548 From $559, Keeps Overweight Rating - MarketScreener

Apr 15, 2025
pulisher
Apr 15, 2025

Idexx Laboratories (IDXX): Morgan Stanley Adjusts Price Target, Maintains Overweight Rating | IDXX Stock News - GuruFocus

Apr 15, 2025
pulisher
Apr 15, 2025

Stifel Adjusts Price Target for Idexx Laboratories (IDXX) Amidst Innovation Analysis | IDXX Stock News - GuruFocus

Apr 15, 2025
pulisher
Apr 14, 2025

Stifel Adjusts IDEXX Laboratories' PT to $420 From $450, Keeps Hold Rating - MarketScreener

Apr 14, 2025
pulisher
Apr 13, 2025

IDEXX Laboratories: I Love The Business, Not The Stock Price (NASDAQ:IDXX) - Seeking Alpha

Apr 13, 2025
pulisher
Apr 10, 2025

IDEXX (IDXX) Surges 10.0%: Is This an Indication of Further Gains? - Yahoo Finance

Apr 10, 2025
pulisher
Apr 09, 2025

IDEXX Laboratories (NasdaqGS:IDXX) Price Moves -14% Over The Last Week Amid Market Volatility - Yahoo Finance

Apr 09, 2025
pulisher
Apr 09, 2025

Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock - Yahoo Finance

Apr 09, 2025
pulisher
Apr 08, 2025

Should You Sell IDEXX Laboratories (IDXX)? - MSN

Apr 08, 2025
pulisher
Apr 04, 2025

How Is The Market Feeling About IDEXX Laboratories? - Benzinga

Apr 04, 2025
pulisher
Apr 03, 2025

IDEXX Laboratories to Release 2025 First Quarter Financial Results - 01net

Apr 03, 2025
pulisher
Apr 03, 2025

Pet Healthcare Leader IDEXX Sets Key Q1 2025 Earnings DateWhat Analysts Are Watching - Stock Titan

Apr 03, 2025
pulisher
Mar 31, 2025

US judge dismisses most of consumer lawsuit over veterinary service prices - Reuters

Mar 31, 2025
pulisher
Mar 30, 2025

We Think IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt With Ease - simplywall.st

Mar 30, 2025
pulisher
Mar 29, 2025

Meet the Little-Known S&P 500 Stock That Has Rocketed 10,230% Higher Since 2000 - Yahoo Finance

Mar 29, 2025
pulisher
Mar 28, 2025

Form DEF 14A IDEXX LABORATORIES INC For: Dec 31 - StreetInsider.com

Mar 28, 2025
pulisher
Mar 28, 2025

Howe & Rusling Inc. Buys New Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat

Mar 28, 2025
pulisher
Mar 26, 2025

Is IDEXX Laboratories, Inc. (IDXX) The Best Pet Stock to Buy According to Billionaires? - Insider Monkey

Mar 26, 2025
pulisher
Mar 26, 2025

8 Best Pet Stocks to Buy According to Billionaires - Insider Monkey

Mar 26, 2025
pulisher
Mar 24, 2025

Why IDEXX Laboratories, Inc. (IDXX) is Among the Best Diagnostics Stocks to Invest in Right Now - Insider Monkey

Mar 24, 2025
pulisher
Mar 24, 2025

IDEXX Laboratories Insiders Sell US$1.9m Of Stock, Possibly Signalling Caution - Yahoo Finance

Mar 24, 2025
pulisher
Mar 23, 2025

12 Best Diagnostics Stocks to Invest In Right Now - Insider Monkey

Mar 23, 2025
pulisher
Mar 18, 2025

Idexx's Economic Moat Remains Solid, but Softer Consumer Confidence Could Weigh on Near Term - Morningstar

Mar 18, 2025
pulisher
Mar 18, 2025

Should You Retain IDEXX Stock in Your Portfolio for Now? - TradingView

Mar 18, 2025
pulisher
Mar 17, 2025

IDEXX Laboratories: Cancer Dx Launch In March 2025; Upgrading To ‘Buy’ (NASDAQ:IDXX) - Seeking Alpha

Mar 17, 2025
pulisher
Mar 14, 2025

Is IDEXX Laboratories Stock Underperforming the Nasdaq? - Nasdaq

Mar 14, 2025
pulisher
Mar 14, 2025

The total return for IDEXX Laboratories (NASDAQ:IDXX) investors has risen faster than earnings growth over the last five years - Simply Wall St

Mar 14, 2025
pulisher
Mar 14, 2025

Is IDEXX Laboratories Stock Underperforming The Nasdaq? - Barchart

Mar 14, 2025
pulisher
Mar 13, 2025

Jones Financial Companies Lllp Sells 194 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - Defense World

Mar 13, 2025
pulisher
Mar 12, 2025

IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory - Insider Monkey

Mar 12, 2025
pulisher
Mar 12, 2025

Two Texas solar plants serve four buyers through energy attribute certificates - pv magazine USA

Mar 12, 2025
pulisher
Mar 12, 2025

X-ELIO closes six US PPAs with Cisco, Biogen, IDEXX, and Waters Corporation - Morningstar

Mar 12, 2025
pulisher
Mar 12, 2025

IDEXX Laboratories: A Top Dog In The Pet Care Market (NASDAQ:IDXX) - Seeking Alpha

Mar 12, 2025
pulisher
Mar 11, 2025

Steward Partners Investment Advisory LLC Purchases 218 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - Defense World

Mar 11, 2025
pulisher
Mar 09, 2025

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by Oppenheimer & Co. Inc. - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

IDEXX Laboratories, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 07, 2025

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Purchased by Assetmark Inc. - MarketBeat

Mar 07, 2025
pulisher
Mar 07, 2025

IDEXX Laboratories (NASDAQ:IDXX) Cut to Hold at StockNews.com - Defense World

Mar 07, 2025
pulisher
Mar 05, 2025

Idexx (IDXX) Down 5% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Mar 05, 2025
pulisher
Mar 01, 2025

FFT Wealth Management LLC Makes New $227,000 Investment in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

Illinois Municipal Retirement Fund Sells 1,017 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by Sigma Planning Corp - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

738 Shares in IDEXX Laboratories, Inc. (NASDAQ:IDXX) Bought by JFG Wealth Management LLC - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

Amalgamated Bank Sells 684 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

IDEXX Laboratories (NASDAQ:IDXX) Upgraded by StockNews.com to "Buy" Rating - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Sterling Investment Advisors Ltd. Buys New Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Fjarde AP Fonden Fourth Swedish National Pension Fund Raises Stock Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Sabal Trust CO Makes New Investment in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Wealthspire Advisors LLC Sells 1,358 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat

Feb 28, 2025

Idexx Laboratories Inc (IDXX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Idexx Laboratories Inc (IDXX) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Smith Martin Alexander
Executive Vice President
Feb 14 '25
Option Exercise
0.00
1,231
0
1,766
Schreck Michael
Executive Vice President
Feb 14 '25
Option Exercise
0.00
1,459
0
2,397
MAZELSKY JONATHAN JAY
President and CEO
Feb 14 '25
Option Exercise
0.00
2,747
0
84,505
Lane Michael
Executive Vice President
Feb 14 '25
Option Exercise
0.00
885
0
7,375
Johnson Michael Perkins
Executive Vice President
Feb 14 '25
Option Exercise
0.00
355
0
585
Hunt Nimrata
Executive Vice President
Feb 14 '25
Option Exercise
0.00
872
0
12,595
FENNELL GEORGE
Executive Vice President
Feb 14 '25
Option Exercise
0.00
304
0
8,480
Erickson Michael G
Executive Vice President
Feb 14 '25
Option Exercise
0.00
557
0
21,393
Erickson Michael G
Executive Vice President
Feb 11 '25
Option Exercise
67.85
1,544
104,760
20,836
FENNELL GEORGE
Executive Vice President
Feb 10 '25
Option Exercise
79.54
9,986
794,286
18,162
diagnostics_research A
$102.48
price down icon 0.21%
diagnostics_research IQV
$143.91
price down icon 3.05%
diagnostics_research MTD
$1,004.96
price down icon 1.15%
$148.08
price down icon 1.39%
diagnostics_research WAT
$321.01
price down icon 0.03%
大文字化:     |  ボリューム (24 時間):